Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiFAB Conditioning for Non-remission Myeloid Malignancies
NCT05807659Phase 2Recruiting
- Sponsor
- Sichuan University
- Start
- Mar 2023
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in myeloid malignancies, sponsored by Sichuan University. Started Mar 2023; status: recruiting.
02
Drugs
tucidinostat
03
Conditions
myeloid malignancies
Beyond the preview
Go deeper on NCT05807659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05807659.